Second messenger molecules allow cells to amplify signals, and rapidly control downstream responses. This concept is illustrated in human cells where mislocalized double-stranded DNA stimulates the cytosolic enzyme cyclic GMP--AMP synthase (cGAS) to synthesize the cyclic dinucleotide (CDN) 2′--5′ / 3′--5′ cyclic GMP--AMP (2′3′ cGAMP)^[@R1],[@R2]^. 2′3′ cGAMP diffuses throughout the cell, activates the receptor Stimulator of Interferon Genes (STING), and induces type I interferon and NF-κB responses to elicit protective anti-viral immunity^[@R1]^. Most recently, synthetic CDN analogues have emerged as promising lead compounds for immune modulation and cancer immunotherapy^[@R2],[@R3]^.

CDNs were first identified in bacteria^[@R4]^ and established the foundation for later recognition of the importance of CDN signaling in mammalian cells^[@R5]^. Nearly all bacterial phyla encode CDN signaling pathways, yet enigmatically, all known natural CDN signals are constructed only from purine nucleotides^[@R6]^. CDNs control diverse responses in bacterial cells. For example, cyclic di-GMP coordinates the transition between planktonic and sessile growth, cyclic di-AMP controls osmoregulation, cell wall homeostasis, and DNA-damage responses, and 3′--5′ / 3′--5′ cGAMP (3′3′ cGAMP) modulates chemotaxis, virulence, and exoelectrogenesis^[@R7]^. The human receptor STING also senses these bacterial CDNs as pathogen (or microbe) associated molecular patterns (PAMPs), revealing a direct, functional connection between bacterial and human nucleotide signaling^[@R8]^. However, our understanding of the true scope of immune responses to bacterial signaling nucleotide-products is limited to cyclic dipurine molecules. Here we describe a systematic approach to understanding the diversity of products synthesized by a family of microbial synthases related to the *Vibrio cholerae* enzyme dinucleotide cyclase in *Vibrio* (DncV) and its metazoan homolog cGAS^[@R9]--[@R11]^.

Discovery of a pyrimidine-containing CDN {#S2}
========================================

The enzyme DncV synthesizes 3′3′ cGAMP and controls a signaling network on the *Vibrio* seventh pandemic island-I (VSP-I), a horizontally acquired genetic element present in all current *V. cholerae* pandemic isolates^[@R11]--[@R13]^. While investigating homologs of *dncV* outside the Vibrionales, we identified an unexpected partial operon in *E. coli* where *dncV* is replaced with a gene of unknown function (WP_001593458, here renamed *cdnE*). The operon architecture implies that *cdnE* may be an alternative 3′3′ cGAMP synthase ([Fig. 1a](#F1){ref-type="fig"}). We tested this hypothesis by incubating purified CdnE protein with α−^32^P radiolabeled ATP, CTP, GTP, and UTP and visualized the reaction products using thin-layer chromatography (TLC). CdnE synthesized a product distinct from currently known CDNs ([Fig. 1b](#F1){ref-type="fig"} and [Extended Data Fig. 1a](#F6){ref-type="fig"} and [b](#F6){ref-type="fig"}). Surprisingly, biochemical deconvolution using pairwise assessment of necessary NTPs revealed that ATP and UTP were necessary and sufficient for product formation ([Fig. 1c](#F1){ref-type="fig"}). We analyzed purified product with nuclease digestion, mass spectrometry and NMR ([Fig. 1d](#F1){ref-type="fig"} and [Extended Data Fig. 1d--l](#F6){ref-type="fig"}), and confirmed that the product of CdnE is cyclic UMP--AMP (cUMP--AMP), a hybrid purine--pyrimidine CDN.

DncV is a structural homolog of cGAS, and each enzyme uses a single active site to sequentially form two separate phosphodiester bonds and release a CDN product^[@R10]^. In spite of no overall sequence homology, careful inspection of the CdnE sequence revealed potential cGAS / DncV-like active site residues (GSYX~10~DVD), which were essential for catalysis ([Extended Data Fig. 1c](#F6){ref-type="fig"}). Reactions with nonhydrolyzable nucleotides confirmed that CdnE catalyzes synthesis of cUMP--AMP using a sequential path through a pppU\[3′--5′\]pA intermediate ([Extended Data Fig. 2](#F7){ref-type="fig"}), and revealed that CdnE is likely a divergent enzyme ancestrally related to cGAS and DncV. We therefore renamed the gene [c]{.ul}GAS / [D]{.ul}ncV-like [n]{.ul}ucleotidyltransferase in [*E*]{.ul}*. coli* (*cdnE*).

In *Vibrio*, DncV controls the activity of cGAMP activated phospholipase in *Vibrio* (CapV), a patatin-like lipase that is a direct 3′3′ cGAMP receptor encoded in the *dncV* operon^[@R14]^. *cdnE* is also preceded by a gene encoding a patatin-like phospholipase (here renamed [c]{.ul}UMP--AMP [a]{.ul}ctivated [p]{.ul}hospholipase in [*E*]{.ul}*. coli, capE*, [Fig. 1a](#F1){ref-type="fig"}) and we hypothesized that this lipase might be activated by cUMP--AMP. CapV and CapE were only activated by the nucleotide synthesized from their adjacently encoded nucleotidyltransferase ([Fig. 1e](#F1){ref-type="fig"}). Importantly, the identification of CapE as a direct cUMP--AMP receptor in *E. coli* confirms that CdnE produces cUMP--AMP to control downstream signaling. The exquisite specificity of CapE insulates this circuit from 3′3′ cGAMP and other parallel CDN signals, potentially explaining the evolutionary advantage of cUMP--AMP and increased CDN diversity.

Mechanism of pyrimidine discrimination {#S3}
======================================

We determined a series of X-ray crystal structures of a CdnE homolog from the thermophilic bacterium *Rhodothermus marinus* (Rm-CdnE, [Fig. 2](#F2){ref-type="fig"}, [Extended Data Fig. 3a](#F8){ref-type="fig"}, and [Supplementary Table 1](#SD2){ref-type="supplementary-material"}). CdnE adopts a Pol-β-like nucleotidyltransferase fold highly similar to cGAS and the core of DncV, confirming a shared structural and evolutionary relationship ([Fig. 2d](#F2){ref-type="fig"}). CdnE is more distantly related to other nucleotidyltransferases including non-templated CCA-adding enzymes, poly(A) polymerases, and templated polymerases such as DNA Polymerase β and μ. The human innate immune enzymes cGAS and Oligo Adenylate Synthase 1 (OAS1) are activated through a conformational change induced by binding a double-stranded nucleic acid^[@R15]^. CdnE, like DncV^[@R10]^, is structurally more similar to the "activated" conformation of these two enzymes, consistent with biochemistry demonstrating CdnE is constitutively active and does not require a cognate stimulus *in vitro*.

The structure of Rm-CdnE in complex with nonhydrolyzable ATP and UTP reveals an asparagine side chain (N166) that forms hydrogen bonds with the uracil base and positions the ATP α-P for attack by the 3′ hydroxyl of UTP ([Fig. 2a](#F2){ref-type="fig"}). N166 is located in the same position as a serine residue in the first acceptor nucleotide pocket of both DncV and cGAS ([Extended Data Fig. 3b](#F8){ref-type="fig"} and [d](#F8){ref-type="fig"}), and we hypothesized that this asparagine substitution might be sufficient to dictate CdnE product specificity. Whereas wild-type CdnE robustly synthesized cUMP--AMP, CdnE^N166S^ incorporated almost no UTP and instead predominantly synthesized c-di-AMP ([Fig. 2c](#F2){ref-type="fig"} and [Extended Data Fig. 3c](#F8){ref-type="fig"}). We surveyed CdnE homologs and determined that N166 is nearly universally conserved ([Fig. 2b](#F2){ref-type="fig"} and [Extended Data Fig. 4a](#F9){ref-type="fig"}). An exception is CdnE from the emerging nosocomial pathogen *Elizabethkingia meningoseptica* (Em-CdnE, [Fig. 2b](#F2){ref-type="fig"})^[@R16]^, which encodes a serine at the analogous position to N166. Unlike the other CdnE homolog, Em-CdnE robustly synthesized cyclic dipurine products ([Fig. 2c](#F2){ref-type="fig"} and [Extended Data Fig. 4b--h](#F9){ref-type="fig"}). Crystal structures of Em-CdnE bound to its nucleotide substrates demonstrated natural N to S reprogramming in the active-site lid, and re-introduction of the ancestral asparagine at this position reverted Em-CdnE back to preferential hybrid purine--pyrimidine product formation ([Supplementary Table 1](#SD2){ref-type="supplementary-material"}, [Fig. 2c](#F2){ref-type="fig"} and [Extended Data Fig. 4f--i](#F9){ref-type="fig"}). These data reveal a remarkably low barrier for altering specificity of CdnE and demonstrate that organisms like *E. meningoseptica* harbor mutations at N166 that reprogram purine and pyrimidine product specificity.

High-resolution structures of cGAS, OAS1, DncV, and two CdnE homologs allowed for the rational definition of shared structural and functional homology. All of these enzymes share three features: (1) a common DNA polymerase β-like nucleotidyltransferase superfamily protein-fold in spite of large sequence divergence, (2) template-independent synthesis of a diffusible molecule through caging of the active site, using a protein scaffold not conserved with more distantly related templated polymerases, and (3) an active site architecture that allows diversification of products and phosphodiester linkage through amino acid substitutions within the active-site lid. We have designated this family of enzymes as CD-NTases ([c]{.ul}GAS / [D]{.ul}ncV-like [N]{.ul}ucleo[t]{.ul}idyltransfer[ases]{.ul}), a structurally and evolutionarily distinct subset of the DNA polymerase β-like nucleotidyltransferase superfamily ([Fig. 2d](#F2){ref-type="fig"}). CD-NTases use distinct enzymatic chemistry and are not structurally related to dimeric GGDEF family c-di-GMP synthases or DAC/DisA family c-di-AMP synthases^[@R17],[@R18]^, and therefore represent a third family of CDN synthase.

CD-NTases and cross-kingdom signaling {#S4}
=====================================

Many bacteria that encode CD-NTases thrive in close proximity to eukaryotic hosts, including humans, plants, and fungi ([Fig. 2b](#F2){ref-type="fig"}). CdnE homologs are found in the intracellular pathogen *Shigella sonnei* and commensal genera such as *Bacteroides* ([Fig. 2b](#F2){ref-type="fig"}). Mammals have evolved a sophisticated surveillance system for detecting and initiating immune responses to bacterial products, including CDNs that are secreted or released during bacteriolysis^[@R19]^. Mouse STING detects bacterial c-di-AMP, c-di-GMP, and 3′3′ cGAMP in addition to endogenously produced 2′3′ cGAMP^[@R1]^. We determined if cUMP--AMP was also recognized by STING or other receptors of the innate immune system. STING bound to all four cyclic dipurine molecules with high affinity and activated type I interferon signaling in cells. However, STING was unable to recognize cUMP--AMP *in vitro* at concentrations known to be sufficient for cyclic dipurine agonists and cUMP--AMP failed to activate STING-dependent type I interferon signaling in cells ([Fig. 3a](#F3){ref-type="fig"} and [Extended Data Fig. 5a](#F10){ref-type="fig"}--[d](#F10){ref-type="fig"}). These data are consistent with previous experiments using chemically synthesized nucleotides^[@R20]^ and were not due to differences in CD-NTase expression levels ([Extended Data Fig. 5c](#F10){ref-type="fig"} and [d](#F10){ref-type="fig"}). In contrast, the recently described mammalian CDN sensor reductase controlling NF-κB (RECON)^[@R21]^ was capable of recognizing cUMP--AMP, and cUMP--AMP inhibited RECON function, albeit with a reduced potency compared to the previously reported inhibition by c-di-AMP and 3′3′ cGAMP ([Fig. 3b](#F3){ref-type="fig"} and [Extended Data Fig. 5e--g](#F10){ref-type="fig"}). RECON bound to cUMP--AMP with a similar low micromolar *K*~d~ to that of STING for c-di-GMP ([Extended Data Fig. 5g](#F10){ref-type="fig"})^[@R8]^, thereby identifying the first host receptor for a naturally occurring purine--pyrimidine hybrid CDN. Whereas the specificity of STING for CDNs is dependent on the presence of two purine bases, RECON requires only the minimal presence of an adenine base in a 3′3′ CDN. These results highlight how discovery of natural bacterial signaling molecules can refine our understanding of host receptor specificity, and demonstrate that the host response may be tuned via multiple receptors that compete for CDNs using distinct rules of engagement.

CD-NTases synthesize diverse nucleotide products {#S5}
================================================

DncV and CdnE evolved from a common ancestor but exhibit dramatic divergence in primary amino acid sequence. We hypothesized that these enzymes comprise only a small fraction of existing bacterial CD-NTase diversity, and that kingdom-wide analysis of the protein family would allow systematic identification of bacterial signaling nucleotides as well as agonists/antagonists of the innate immune system. We therefore coupled bioinformatic analysis with a large-scale, forward biochemical screen to directly uncover additional nucleotide products. Previously, Burroughs et al. used a hidden Markov model derived from cGAS and DncV and conserved operon structures to identify potentially related bacterial proteins^[@R22]^. Building upon this previous analysis, we identified \>5,600 unique bacterial enzymes predicted to share common CD-NTase structural features ([Fig. 4a](#F4){ref-type="fig"}, [Extended Data Fig. 6a](#F11){ref-type="fig"}, and [Supplementary Table 2](#SD1){ref-type="supplementary-material"}). CD-NTases were identified in \>10% of bacterial genomes available in the NCBI database, within taxa that span nearly every bacterial phylum ([Extended Data Fig. 6b](#F11){ref-type="fig"}). Bacteria harboring CD-NTase genes include human commensal organisms (e.g., Clostridiales, and Fusobacteria), human pathogens (e.g., *Listeria*, *Shigella*, and *Salmonella* species), extremophiles, and agriculturally significant bacteria (e.g., rhizobia commensals and plant pathogens such as *Xanthomonas*). Although CD-NTases are found in many different organisms, they are typically not encoded in the core genome and are found in specific strains from each species. Sequence alignments revealed that CD-NTases cluster into roughly eight clades that we designated A--H starting with A for the DncV-harboring clade, E for the CdnE containing clade, and continued to the letter H. We further divided highly-related sequences into clusters, which often grouped bacterial species that occupy a similar niche, such as plant rhizobia in cluster G10 ([Fig. 4a](#F4){ref-type="fig"} and [Supplementary Table 2](#SD1){ref-type="supplementary-material"}).

We purified 66 CD-NTase proteins and tested each for nucleotide product synthesis ([Fig. 4a](#F4){ref-type="fig"} and [Extended Data Fig. 6c--g](#F11){ref-type="fig"}). These proteins were selected as type enzymes from each cluster based on the relevance of the organism from which they were isolated (pathogens, commensals, and bacteria predicted to interact with eukaryotes) and the frequency at which each sequence has been re-isolated from multiple organisms. Recombinant proteins were screened using a broad range of reaction conditions to identify robust activity. Despite encoding an intact active site, no activity was observed from any representative of some CD-NTase clusters. These enzymes may function similarly to human cGAS and OAS1 where a cognate ligand (e.g., dsDNA and dsRNA) is required to stimulate enzyme activity, or it is possible that these clusters may utilize building blocks other than ribonucleotide triphosphates for product synthesis.

The 16 most active CD-NTases were selected for in-depth analysis ([Fig. 4b](#F4){ref-type="fig"} and [c](#F4){ref-type="fig"}). Our previous results established that cyclic dipurine and cyclic purine--pyrimidine hybrid molecules migrate at the bottom and middle of PEI-cellulose TLC plates, respectively. In the collection of active CD-NTase representatives, several enzymes produced products that migrated at the top of the plate, even more rapidly than cUMP--AMP. Further biochemical analysis of CD-NTase057, (renamed Lp-CdnE02) from *Legionella pneumophila* (strain 12_4117) demonstrated that this class of PEI-cellulose TLC species corresponded to cyclic dipyrimidines, and Lp-CdnE02 synthesized predominantly c-di-UMP ([Fig. 4b](#F4){ref-type="fig"}--[d](#F4){ref-type="fig"}, and [Extended Data Fig. 7](#F12){ref-type="fig"}). Lp-CdnE02 also harbors an asparagine residue analogous to N166 of Rm-CdnE, a feature found in nearly all CD-NTases in clade E but not found in other clades. Mass spectrometry of each CD-NTase reaction coupled with NTP substrate dependency profile and TLC data allowed us to identify the products produced by different CD-NTases and estimate their abundance ([Fig. 4d](#F4){ref-type="fig"}). The 16 active, representative enzymes produced 7 purine, pyrimidine, and purine--pyrimidine hybrid CDN combinations, demonstrating that CD-NTase enzymes synthesize an extraordinarily diverse array of bacterial nucleotide signals ([Fig. 4d](#F4){ref-type="fig"}).

CD-NTases are encoded in conserved operons on mobile genetic elements {#S6}
=====================================================================

A unifying characteristic of almost all CD-NTase-encoding genes is their location within similar operons in predicted mobile genetic elements ([Extended Data Fig. 8a](#F13){ref-type="fig"}). Often genes encoding identical CD-NTase proteins are found in specific strains of unrelated bacterial species, reflecting that these genes are members of the "mobilome" (for detail on identifying CD-NTases within an organism of interest, see [Supplementary Discussion](#SD2){ref-type="supplementary-material"}). The horizontal acquisition of CD-NTases suggests that they are likely to provide a selective advantage, may not alter species-specific nucleotide signaling networks, and instead alter bacterial physiology via receptors adjacently encoded, similar to *capV-dncV* and *capE-cdnE*. Burroughs et al. noted that genes adjacent to CD-NTases are effector-like and are generally involved in biological conflict, including phospholipases, nucleases, and pore-forming agents^[@R22]^. Coexpression of *dncV* and *capV* is toxic to *E. coli*^[@R14]^ and we tested if coexpression of each CD-NTase with its adjacently-encoded, putative receptor was also toxic to *E. coli*. Expression of *dncV-capV* was unique in inhibiting colony formation and other CD-NTase-predicted receptor pairs, including the *cdnE-capE* pair, did not impair bacterial growth ([Extended Data Fig. 8b](#F13){ref-type="fig"} and [c](#F13){ref-type="fig"}). However, it is unclear if CD-NTases are constitutively active *in vivo* or exhibit regulated enzymatic activity like the metazoan second messenger synthase cGAS. These findings demonstrate that phenotypes observed with *Vibrio dncV-capV* may not be indicative of general CD-NTase function, and that CD-NTase-containing islands may perform functions such as mediating bacteriophage resistance, modulating bacterial-host interactions, functioning as addiction modules, or regulating bacteriolysis for dissemination of mobile genetic elements.

Bacteria CD-NTase products include cyclic trinucleotide signals {#S7}
===============================================================

Surprisingly, we were unable to identify expected CDNs by mass spectrometry in some reactions despite visualizing robust product formation by PEI-cellulose TLC. Using orthogonal TLC conditions, these unknown products exhibited distinct migration patterns that suggested existence of unique non-CDN species ([Fig. 4c](#F4){ref-type="fig"} and [4d](#F4){ref-type="fig"}). We focused on an orphan product of CD-NTase038 (renamed Ec-CdnD02) from *Enterobacter cloacae* (strain UCI 50) for identification. The Ec-CdnD02 product initially appeared to be a cyclic dipurine by PEI-cellulose TLC, but the major Ec-CdnD02 product displayed a unique migration pattern when analyzed by silica TLC ([Fig. 5a](#F5){ref-type="fig"} and [Extended Data Fig. 9a](#F14){ref-type="fig"}). ATP and GTP were necessary and sufficient for product formation, however, roughly two thirds of the total α^32^-P was incorporated from ATP and the remaining third from GTP. Consistent with this pattern, re-evaluation of the mass spectrometry data and subsequent biochemical and NMR validation revealed that cyclic AMP--AMP--GMP (cAAG), a cyclic trinucleotide, is the major product of Ec-CdnD02 ([Fig. 5b](#F5){ref-type="fig"} and [Extended Data Fig. 9b--j](#F14){ref-type="fig"}).

Similar to cUMP--AMP, the bacterial cyclic trinucleotide cAAG escaped STING recognition but was detected by RECON, confirming our new definition of STING and RECON ligand specificity ([Fig. 5c](#F5){ref-type="fig"}, [Extended Data Fig. 10a](#F15){ref-type="fig"} and [f](#F15){ref-type="fig"}). We next determined a co-crystal structure of RECON in complex with the Ec-CdnD02 cyclic trinucleotide product ([Fig. 5d](#F5){ref-type="fig"}, [Extended Data Fig. 10](#F15){ref-type="fig"}, and [Supplementary Table 1](#SD2){ref-type="supplementary-material"}). The structure further confirms that the bacterial cyclic trinucleotide is cAAG and contains exclusively 3′--5′ phosphodiester linkages. The two adenine bases are coordinated in the same adenine and nicotinamide pockets observed in the previous structure of RECON bound to bacterial c-di-AMP^[@R21]^, but unexpectedly RECON E28 makes additional contacts with the third guanine base of the cAAG species as part of an extended base platform not required for CDN recognition. E28 is highly conserved, potentially indicating that RECON may have evolved to allow recognition of additional bacterial or host cyclic trinucleotide species. This unexpected class of nucleotide product reveals that the active site of CD-NTase enzymes can be adapted to synthesize larger cyclic oligonucleotide products, and that host immune receptors are capable of recognizing bacterial cyclic trinucleotide species. Recently, cyclic oligoadenylate synthesized by Cas10 was demonstrated to be a key signaling molecule in type III CRISPR immunity^[@R23],[@R24]^. Although CD-NTases have no homology with Cas10, these parallel findings indicate that larger cyclic oligonucleotide products may be more common in bacterial signaling and host recognition than previously expected.

CD-NTases in health and disease {#S8}
===============================

Our data demonstrate that bacterial CD-NTases are widespread and synthesize diverse CDNs that include pyrimidine nucleotides and additional cyclic trinucleotide compounds. CD-NTases join the GGDEF and DAC/DisA domains, responsible for c-di-GMP and c-di-AMP synthesis^[@R17],[@R18]^, as a third major family of enzymes that control downstream signaling using CDN signals. Distinguishing features of CD-NTases are their location on mobile genetic elements, extreme sequence diversity, and reaction mechanism reliant on a monomeric enzyme active site. Recent evidence demonstrates divergent GGDEF family enzymes produce 3′3′ cGAMP in addition to c-di-GMP^[@R25],[@R26]^, suggesting that the selective pressures driving CD-NTase diversity may also be in effect for GGDEF and DAC/DisA-like synthases.

Understanding the functional role of CD-NTase genes in the biology of bacteria and host-microbe interactions is a major challenge for future studies. Mammalian receptors recognize diverse CD-NTase products, and CD-NTase genes may provide a selective advantage for some bacterium-eukaryote interactions. Our data show that a single mutation in a CD-NTase enables incorporation of pyrimidines and indicate that bacteria may evade or enhance STING signaling by modulating enzyme specificity. The possibility that diverse CDNs and related nucleotide signals produced by prokaryotic CD-NTases act as agonists and inhibitors of innate immunity and other host metabolic pathways provides an important new reservoir of compounds with biotechnology and therapeutic applications.

Methods {#S9}
=======

Bacterial strains and growth conditions {#S10}
---------------------------------------

*E. coli* was cultivated at 37 °C, shaking, in LB medium (1% tryptone, 0.5% yeast extract, 0.5% NaCl w/v), and stored in LB plus 30% glycerol at −80 °C unless otherwise indicated. When appropriate, carbenicillin (100 μg mL^−1^), ampicillin (100 μg mL^−1^), and chloramphenicol (20--34 μg mL^−1^) were used. BL21 *E. coli* (strain CodonPlus (DE3)-RIL transformed with pRARE2, Agilent) was used for all protein expression and DH10β *E. coli* (strain Top10, Invitrogen) was used for cloning and plasmid propagation. For repression of protein expression from pET vectors, BL21 *E. coli* was cultivated in MDG medium (0.5% glucose, 25 mM Na~2~HPO~4~, 25 mM KH~2~PO~4~, 50 mM NH~4~Cl, 5 mM Na~2~SO~4~, 2 mM MgSO~4~, 0.25% aspartic acid, and trace metals) with ampicillin and chloramphenicol. For optimum protein expression from pET vectors, BL21 *E. coli* was cultivated in M9ZB medium (0.5% glycerol, 1% Cas-Amino Acids, 47.8 mM Na~2~HPO~4~, 22 mM KH~2~PO~4~, 18.7 mM NH~4~Cl, 85.6 mM NaCl, 2 mM MgSO~4~, and trace metals) with ampicillin and chloramphenicol^[@R27]^.

Cloning and plasmid construction {#S11}
--------------------------------

Cloning and plasmid construction were performed as previously described^[@R28]^. Briefly, for vectors constructed in this study, genes were either amplified from genomic DNA or synthesized as gBLOCKs (Integrated DNA Technologies) with ≥18 base pairs of homology flanking the insert sequence and ligated into restriction endonuclease linearized vector by Gibson assembly. Reactions were transformed into electrocompetent DH10β and selected with appropriate antibiotic plates. Sanger sequencing confirmed each vector was free of mutations within the multiple cloning site. N-terminal 6×His-MBP tag and 6×His-SUMO2 tag fusions were constructed using custom pET16MBP^[@R29]^ or pETSUMO2^[@R30]^ vectors, respectively. cGAS standards used *Homo sapiens CGAS*, DisA standards used *Bacillus thuringiensis disA,* and WspR standards used *Pseudomonas aeruginosa wspR* with a D70E constitutively activating mutation^[@R31]^. CD-NTases and their effector coding sequences were codon optimized for bacterial expression (Integrated DNA Technologies) with the exception of genes derived from *E. coli* strain ECOR31^[@R32]^ (ATCC 35350) and *V. cholerae* strain C6706. Synthases were overexpressed in mammalian cells from pcDNA4 plasmids as previously described^[@R33]^. For expression of MBP N-terminally tagged *dncV* and *cdnE* in mammalian cells, MBP and the fused CD-NTase were codon optimized for expression in human cells. For coexpression with their putative effector genes, N-terminal MBP-tagged CD-NTases were cloned into pBAD33^[@R34]^ modified with a ribosomal binding site and oriT for conjugation. For cloned CD-NTase details see [Supplementary Table 2](#SD1){ref-type="supplementary-material"} and for cloned CD-NTase effector details see [Supplementary Table 3](#SD1){ref-type="supplementary-material"}.

Recombinant protein purification {#S12}
--------------------------------

Proteins were purified as previously described^[@R30]^. Briefly, chemically competent BL21 *E. coli* was transformed with a protein expression plasmid, recovered on MDG plates overnight, cultivated as a 30 mL starter culture in MDG liquid medium overnight at 37 °C with 230 RPM shaking, and used to seed an M9ZB culture at \~1:1000. 25 mL or 2× 1 L M9ZB cultures were cultivated for \~5 h at 37 °C with 230 RPM shaking until OD was 2--3.5 at which time cells were chilled on ice for 20 min, IPTG was added at 0.5 mM and cultures were shifted to 16 °C with shaking 230 RPM overnight. Harvested *E. coli* was washed in 1× PBS, stored as a flash-frozen pellet at −80 °C or immediately disrupted by sonication in lysis buffer (20 mM HEPES-KOH pH 7.5, 400 mM NaCl, 30 mM imidazole, 10% glycerol, 1 mM DTT). Lysates were clarified by centrifugation, filtered through glass wool, and proteins were purified by affinity chromatography using Ni-NTA (Qiagen) resin and a gravity column. Resin was washed (lysis buffer supplemented to 1 M NaCl), eluted (lysis buffer supplemented to 300 mM imidizole), and eluate was dialyzed overnight at 4 °C (20 mM HEPES-KOH pH 7.5, 300 mM NaCl, 1 mM DTT). For SUMO2 fusion proteins, dialysis was supplemented with \~250 μg of human SENP2 protease (D364--L589, M497A)^[@R35]^. Small-scale preparations of proteins were flash-frozen at this stage and stored at −80 °C in storage buffer (10% glycerol, 20 mM HEPES-KOH pH 7.5, 250 mM KCl, 1 mM TCEP). Where appropriate, proteins were filter-concentrated using centrifugation and a 10 kDa or 30 kDa cut-off column (Millipore Sigma).

For large-scale protein preps (cGAS, DncV, DisA, CdnE, Rm-CdnE, Em-CdnE, STING, RECON, Lp-CdnE02, Ec-CdnD02, CyaA), size exclusion chromatography followed by concentration was performed in storage buffer without glycerol. Initial CD-NTase proteins were purified and screened as N-terminal MBP fusions to increase expression and stability. Proteins were either freshly thawed from −80 °C stocks and immediately used or maintained at −20 °C in a storage buffer with 50% total glycerol. Glycerol stocks of CD-NTases stored at −20 °C retain \>90% activity for \>6 months and were used for biochemical assays.

Biochemistry and nucleotide synthesis assays {#S13}
--------------------------------------------

Recombinant CD-NTase reactions combined: 4 μL of 5× reaction buffer (250 mM CAPSO pH 9.4, 175 mM KCl, 25 mM Mg(OAc)~2~, 5 mM DTT), 2 μL of 10× NTPs, 1 μL \[ɑ−^32^P\] NTPs (\~1 μCi), 1 μL of candidate enzyme in storage buffer (\~20 μM), and a remaining volume of nuclease free water for a total reaction volume of 20 μL. The final reactions (50 mM CAPSO pH 9.4, 50 mM KCl, 5 mM Mg(OAc)~2~, 1 mM DTT, ≤5% glycerol, 25--250 μM individual NTPs, trace amounts of \[ɑ−^32^P\] NTP, 1 μM enzyme) were started with addition of enzyme. Where indicated, pH was altered by replacing CAPSO buffer with appropriate buffer from a StockOptions pH Buffer Kit (Hampton Research). When appropriate, Mg^2+^ was replaced with an equimolar concentration of Mn^2+^ (MnCl~2~). cGAS reactions were carried out with Tris at pH 7.5 and supplemented with 1 μM ISD45 dsDNA^[@R36]^. Reactions were carried out with 25 μM of each indicated NTP for Figures [1b](#F1){ref-type="fig"}, [2c](#F2){ref-type="fig"}, and [4b--c](#F4){ref-type="fig"} and for Extended Data Figures [1d](#F6){ref-type="fig"}, [2a--c](#F7){ref-type="fig"}, [4c](#F9){ref-type="fig"}, [6c--f](#F11){ref-type="fig"}, [7a--c](#F12){ref-type="fig"}, [8d](#F13){ref-type="fig"}. Reactions in all other figures were carried out with 250 μM NTP. The NTP/\[ɑ−^32^P\] NTPs in [Fig. 1b](#F1){ref-type="fig"} are cGAS (ATP, GTP/\[ɑ−^32^P\] GTP), DncV (ATP, GTP/\[ɑ−^32^P\] ATP), DisA (ATP /\[ɑ−^32^P\] ATP), WspR (GTP /\[ɑ−^32^P\] GTP), and CdnE (NTP /\[ɑ−^32^P\] NTP). Nuclease P1 treated reactions in Extended Data Figures [1d](#F6){ref-type="fig"} and [7c](#F12){ref-type="fig"} are cGAS (ATP, GTP/\[ɑ−^32^P\] ATP), DncV (ATP, GTP/\[ɑ−^32^P\] GTP), CdnE (ATP, UTP/\[ɑ−^32^P\] ATP), and Lp-CdnE02 (CTP, UTP/\[ɑ−^32^P\] UTP). Where indicated, nonhydrolyzable nucleotides \[Ap(c)pp, Gp(c)pp, Cp(c)pp, or Up(n)pp (Jena Bioscience)\] were used at 25 μM.

Reactions were incubated for 2 h at 37 °C prior to analysis unless otherwise stated. Reactions were stopped by addition of 5 U of alkaline phosphatase (New England Biolabs) which removed triphosphates on remaining NTPs and converted the remaining nucleotide ɑ−^32^P to ^32^P~i~ allowing visualization of cyclized species. After a ≥20 min incubation, 0.5 μL (PEI-cellulose) or 1 μL (silica) of the reaction was spotted 1.5 cm from the bottom of the TLC plate, spaced 0.8 cm apart. When migration of P~i~ appeared inconsistent (e.g. due to variability in pH) samples were diluted 10-fold in 100 mM sodium acetate pH 5.2. 20 cm × 20 cm F-coated PEI-cellulose TLCs (Millipore) were developed in 1.5 M KH~2~PO~4~ (pH 3.8) until the buffer front reached \~1 cm from the top; 20 cm × 10 cm F-coated silica HP-TLC plates (Millipore) were developed in 11:7:2 1-propanol: NH~4~OH: H~2~O in a chemical fume hood for 1 h. Plates were dried and exposed to a phosphorscreen prior to detection by Typhoon Trio Variable Mode Imager system (GE Healthcare).

Nucleotide synthesis and purification {#S14}
-------------------------------------

Cyclic dinucleotides and oligonucleotides were produced in large scale using previously described methods^[@R37]^ with the following changes. Small-scale nucleotide synthesis assays were scaled up to 10--40 mL reactions with final conditions of 50 mM CAPSO pH 9.4, 12.5--50 mM K/NaCl, 5--20 mM Mg(OAc)~2~, 1 mM DTT, ≤5% glycerol, 250 μM individual NTPs, and 1 μM enzyme. A 20 μL aliquot of the larger reaction was removed and \[ɑ−^32^P\] NTPs were added to monitor reaction progress. Reactions were incubated for 24 h at which time 5 U mL^−1^ of alkaline phosphatase (New England Biolabs) was added and the reaction was further incubated for 2--24 hours. Reactions were heat inactivated at 65 °C for 30 min, diluted to a final salt concentration of 12.5 mM, and purified by anion exchange chromatography and FPLC (either 1 mL Q-sepharose column or Mono Q 4.6/100 PE, GE Healthcare). The column was washed with water and 1 mL fractions were collected during a gradient elution with 2 M ammonium acetate. Fractions harboring the appropriate product were identified by A~260~ and silica TLC, visualizing the nucleotide products by UV-shadowing, imaging using a handheld camera, and comparing migration to paired, radiolabeled reactions detected by phosphorimaging. Selected fractions were concentrated by evaporation and re-suspended in 30 μL of nuclease free water for MS. For NMR, nucleotides were further purified using size chromatography (Superdex 30 Increase 10/300 GL, GE Healthcare). The column was equilibrated with H~2~O running buffer and 1 mL fractions were collected, identified by A~260~, pooled, and evaporated. Concentrations of purified nucleotides were estimated from A~260~ using the estimated extinction coefficients based on RNA oligonucleotides: cUMP--AMP ε=22,800 L mole^−1^ cm^−1^, cAAG ε=37,000 L mole^−1^ cm^−1^.

Mass spectrometry {#S15}
-----------------

ESI-LC/MS analysis was performed using an Agilent 6530 QTOF mass spectrometer coupled to a 1290 infinity binary LC system operating the electrospray source in positive ionization mode. All samples were chromatographed on an Agilent ZORBAX Bonus-RP C18 column (4.6 × 150 mm; 3.5 μm particle size) at 50 °C column temperature. The solvent system consisted of 10 mM ammonium acetate (A) and methanol (B). The HPLC gradient with a flow rate of 1 ml min^−1^ starts at 5% B, holds for 2 min and then increases over 12 min to 100% B. Identification of CDNs and cAAG was performed by targeted mass analysis for exact masses and formulae for all possible CDNs and cAAG using Profinder software (version B.06.00 build 6.0.606.0, Agilent).

NMR {#S16}
---

All NMR experiments were conducted on a Varian 400-MR spectrometer (9.4 T, 400 MHz). Samples were prepared by re-suspending evaporated nucleotide samples in 500 μL D~2~O supplemented with 5 mM TMSP (3-(trimethylsilyl)propionic-2,2,3,3-d~4~) at 27 °C. Data were processed and figures were generated using VnmrJ software (version 2.2C). ^1^H and ^31^P chemical shifts are reported in parts per million (ppm). J coupling constants are reported in units of frequency (Hertz) with multiplicities listed as s (singlet), d (doublet), and m (multiplet). These data appear in the figure legends of each NMR spectra.

Phospholipase assay {#S17}
-------------------

Patatin-like lipases were assayed as previously described^[@R38]^. Briefly, CapV and CapE were produced recombinantly and catalytic activity was measured using the EnzChek Phospholipase A1 Assay Kit (Invitrogen) according to the manufacturer's instructions. Phospholipases (250 nM) were incubated with 2.5, 0.25, or 0.025 μM CDN. c-di-AMP (Invivogen), 3′3′ cGAMP (Invivogen), and c-di-GMP (Biolog) were purchased as chemical standards, cUMP--AMP was purified as described above. Assays were monitored fluorometrically (Ex = 460 nm / Em = 515 nm) for 60 min at \~90 s intervals at room temperature using a Biotek Synergy plate reader. Slope of each reaction in the linear range was used to calculate activity (Linear regression/straight line analysis, Prism 7.0c). A PLA1 standard curve from 20--0.02 U was used to interpolate phospholipase activity. Emission was monitored at a gain of 100 and/or 50 in order to extend the linear range of the assay.

Crystallization and structure determination {#S18}
-------------------------------------------

CdnE homologs were crystallized in *apo* form or in complex with nucleotide substrates at 18 °C using hanging drop vapor diffusion. Purified Rm-CdnE and Em-CdnE were diluted on ice to 7--10 mg ml^−1^ and used immediately to set trays. Alternatively, co-complex crystals were grown by first incubating Rm-CdnE and Em-CdnE in the presence of \~10 mM total combined nucleotide concentration and 10.5 mM MgCl~2~ on ice for 30 min. RECON--cAAG co-complex crystals were grown by pre-incubating \~10 mg ml^−1^ RECON (K68A K70A) with 1 mM of purified Ec-CdnD02 product. Following incubation, 2 μl hanging drops were set at a ratio of 1:1 or 1.2:0.8 (protein:reservoir) over 350 μl of reservoir in Easy-Xtal 15-Well trays (Qiagen). Optimized crystallization conditions were as follows: *Apo* Rm-CdnE 100 mM Tris-HCl pH 7.5, 10--20% ethanol; Rm-CdnE--Apcpp--Upnpp 0.24 M sodium malonate, 24% PEG-3350; *Apo* Em-CdnE 21 mM sodium citrate pH 7.0, 100 mM HEPES-KOH pH 7.5, 16% PEG-5000 MME; Em-CdnE--GTP--Apcpp 100 mM tri-sodium citrate pH 6.4, 10% PEG-3350; Em-CdnE--pppApA 100 mM tri-sodium citrate pH 7.0, 8% PEG-3350; RECON--cAAG 0.1 M NaOAc, 1.0 M LiCl, 30% PEG-6000. Crystals grew in 3--30 days, and all crystals were harvested using reservoir solution supplemented with 10--25% ethylene glycol using a nylon loop except *Apo* Rm-CdnE crystals were harvested using NVH oil. X-ray diffraction data were collected at the Advanced Light Source (beamlines 8.2.1 and 5.0.1) and the Advanced Photon Source (beamlines 24-ID-C and 24-ID-E).

Data were processed with XDS and AIMLESS^[@R39]^ using the SSRL *autoxds* script (A. Gonzalez, Stanford SSRL). Experimental phase information for Rm-CdnE was determined using data collected from crystals grown with selenomethionine-substituted protein as previously described^[@R10]^. 4 sites were identified with HySS in PHENIX^[@R40]^, and an initial map was calculated using SOLVE/RESOLVE^[@R41]^. Model building was completed in Coot^[@R42]^ prior to refinement in PHENIX. Following model completion, the *Apo* Rm-CdnE structure was used for molecular replacement to determine the nucleotide bound structures. Rm-CdnE models were not sufficient to phase Em-CdnE data, but a minimal core Rm-CdnE active-site model was able to successfully determine the substructure and assist experimental phasing with data collected from a native crystal using sulfur single-wavelength anomalous dispersion at a minimal accessible wavelength (\~7,235 eV). 16 heavy sites were identified in HySS that correspond to 12 sulfur, and 4 phosphate sites in the Em-CdnE--pppApA structure, and Em-CdnE model building was completed as for Rm-CdnE. RECON--cAAG data were phased by molecular replacement using the previously determined RECON--c-di-AMP structure (PDB 5UXF^[@R21]^), and model building was manually completed in Coot. X-ray data for refinement were extended according to I/σ resolution cut-off of \~1.5 and CC\* correlation and Rpim parameters. Final structures were refined to stereochemistry statistics for Ramachandran plot (favored/allowed), rotamer outliers, and MolProbity score as follows: Rm-CdnE *Apo*, 98.6%/1.4%, 0.4% and 0.98; Rm-CdnE--Apcpp--UpNpp, 98.9%/1.1%, 0.4% and 1.25; Em-CdnE *Apo* 97.8%/2.2%, 0.8% and 1.08, Em-CdnE--GTP--Apcpp, 97.8%/2.2%, 0.8%, and 1.05, Em-CdnE--pppApA, 98.1%/1.9%, 0.8%, and 1.29. See [Supplementary Table 1](#SD2){ref-type="supplementary-material"} and the Data Availability section for deposited PDB codes.

Structural comparisons {#S19}
----------------------

Structure-based comparisons used to define the conserved CD-NTase architecture in [Fig. 2d](#F2){ref-type="fig"} were calculated using the Dali server and enzymes were clustered according to Z-score^[@R43]^ of the core NTase domain. Structures used include: DncV (4TY0^[@R10]^), cGAS (6CTA^[@R30]^), OAS1 (4RWO^[@R44]^), Poly(A) Polymerase gamma (PAP, 4LT6^[@R45]^), CCA-adding enzyme (4X4T^[@R46]^), Pol-β (4KLQ^[@R47]^), and Pol-μ (4YD1^[@R48]^).

In the text and in figures, side-chains are numbered according to Rm-CdnE sequence. The analogous residue to N166 from Rm-CdnE in *E. coli* CdnE is N174, in Em-CdnE is S169, in DncV is S259, and in human cGAS is S378. RECON crystal structures with cAAG, c-di-AMP (5UXF^[@R21]^), and NAD (3LN3) were superimposed using PyMol (version 1.7.4.4), and all structure figures were prepared using PyMol.

Gel shift assays {#S21}
----------------

*In vitro* binding assays were performed as previously described^[@R33]^. Briefly, recombinant *Mus musculus* STING or RECON, at 4, 20, or 100 μM was incubated with radiolabeled nucleotide (≤1 μM final concentration) in gel shift buffer for final conditions of 50 mM Tris pH 7.5, 60 mM KCl, 5 mM Mg(OAc)~2~, and 1 mM DTT. Experiments were prepared by combining 1 μL of α−^32^P labeled nucleotide, 2 μL 5× gel shift buffer, 5 μL of nuclease free water, and started by addition of 2 μL of recombinant protein in storage buffer. α−^32^P labeled nucleotides were produced with 25 μM of each NTP and \~1 μCi of each \[α−^32^P\] NTP in the following conditions: cGAS (ATP, GTP/\[ɑ−^32^P\] GTP), DncV (ATP, GTP/\[ɑ−^32^P\] ATP), DisA (ATP /\[ɑ−^32^P\] ATP), WspR (GTP /\[ɑ−^32^P\] GTP), CdnE (ATP, UTP /\[ɑ−^32^P\] UTP), and Ec-CdnD02 (ATP, GTP/\[ɑ−^32^P\] GTP).

After 30 min of equilibration, bound and free nucleotide were separated by 6% native PAGE in 0.5× TBE buffer, gels were dried, and exposed to a phosphorscreen prior to detection by Typhoon Trio Variable Mode Imager system (GE Healthcare). Gel shifts were quantified with ImageQuant 5.2 and the percent bound nucleotide was calculated as a proportion of total bound and free nucleotide for each lane, after subtraction of background signal.

Cellular assays for interferon-β induction {#S22}
------------------------------------------

In-cell assays were performed as previously described^[@R33]^. Briefly, HEK293T cells were transfected using Lipofectamine2000 in 96-well format with: a control plasmid constitutively expressing *Renilla* luciferase (2 ng pRL-TK), a reporter plasmid expressing interferon-β inducible firefly luciferase (20 ng), a plasmid expressing *Mus musculus* STING (5 ng), and a 5-fold dilution series of pcDNA4-based plasmids expressing a nucleotidyltransferase (1.2, 6, 30, 150 ng). 2′3′ cGAMP was produced with mouse cGAS, 3′3′ cGAMP was produced with *V. cholerae* DncV, cyclic di-AMP (cAA) was produced with *Bacillus subtilis* DisA, cyclic di-GMP (cGG) was produced with *P. aeruginosa* WspR. Luciferase production was quantified after 24 h and firefly luciferase was normalized to *Renilla*, which was then normalized to empty nucleotidyltransferase vector used at 150 ng.

Cell lines {#S23}
----------

HEK293T cells were used to measure a reporter plasmid expressing interferon-β inducible firefly luciferase. Cell lines were originally provided by the ATCC, no methods were used for authentication, and cell lines were not tested for mycoplasma.

Western blot analysis {#S24}
---------------------

CD-NTase in-cell expression levels were verified by Western blot of lysed cells. Confluent HEK293T cells were seeded 24 h prior to transfection at a dilution of 1:4 in a 6-well dish. Cells were transfected with 2 μg of plasmid using Lipofectamine2000. At 24 h post transfection cells were harvested by washing cells from the dish using Hanks Buffered Saline Solution, pelleted at low speed, and flash frozen. Pelleted cells were lysed by re-suspending the pellet in 400 μL 1x LDS buffer (ThermoFisher Scientific) + 5% β-mercaptoethanol, boiling for 5 min, and vigorously vortexing. Samples were separated by SDS-PAGE, transferred to nitrocellulose membrane, and probed with primary antibodies 1:5,000 Rabbit anti-MBP (Millipore Cat\# AB3596, RRID:AB_91531) and 1:10,000 Mouse anti-Tubulin (Millipore Cat\# MABT205, RRID:AB_11204167), followed by secondary antibodies at 1:10,000 IRDye 680RD Goat anti-Rabbit IgG (LI-COR Biosciences Cat\# 925--68071, RRID:AB_2721181) and IRDye 800CW Goat anti-Mouse IgG (LI-COR Biosciences Cat\# 925--32210, RRID:AB_2687825). Stained membrane was imaged using a LI-COR Odyssey CLx imager.

RECON enzyme assay {#S25}
------------------

Activity assays were performed as previously described^[@R21]^. Briefly, a 2-fold dilution series of nucleotide from 50--0.05 μM was incubated in 1× PBS with 200 μM NADPH (co-substrate) and 25 μM 9,10-Phenanthrenequinone (substrate). The reactions were started with the addition of RECON to a final concentration of 0.5 μM and absorbance at 340 nm was monitored at 20 s intervals for 20 min. The slope of each reaction in the linear range (20--250 s) was used to calculate activity (Linear regression/straight line analysis, Prism 7.0c). Values were normalized to reactions with no CDN/nucleotide signaling molecule added, which defined 100% activity. Nucleotides were produced or purchased as described above and cAAG was purified as described above.

Bioinformatics and tree construction {#S26}
------------------------------------

To bioinformatically map CD-NTase-like enzymes in bacteria, we extended a previous analysis by Burroughs et al. that combined iterative BLAST analysis, secondary structure predictions, and hidden Markov models to collect DncV-like proteins and their genomic context^[@R22]^. We identified homologs of each of these 1300 identified proteins by BLAST analysis of the NCBI non-redundant protein database, then combined these datasets to identify \>5600 CD-NTase-like genes. The dataset was then manually curated (Geneious Software) according to shared CD-NTase structural and active-site features. Bacterial genomes and sequences were aligned using MAFFT FFT-NS-2 algorithm v7.388^[@R49]^, a BLOSUM62 scoring matrix, an open gap penalty of 2, and an offset value of 0.123. Proteins with large truncations or lacking the essential DNA polymerase β-like nucleotidyltransferase residues \[ie. GS...(D/E)X(D/E)...(D/E)\] were removed. The tree was generated from the MAFFT alignment using a Jukes-Cantor genetic distance model, Neighbor-Joining method, no outgroup, and resampled by Bootstrap for 100 replicates sorted by topologies. The unrooted tree is used to represent global CD-NTase diversity and does accurately reflect the specific evolutionary relationship between the major CD-NTase A--H clades. The aligned sequences along with pairwise identity comparisons were extracted and used to define clades and clusters. A cluster was defined as \>10 CD-NTases that share \>24.5 % identity to the sequence preceding each in the alignment. For clarity, 14 poorly aligned CD-NTases were excluded from the tree and are indicated in [Supplementary Table 2](#SD1){ref-type="supplementary-material"}. The full dataset organized by order from the alignment and containing pairwise comparison of protein identity to each preceding gene is available as [Supplementary Table 2](#SD1){ref-type="supplementary-material"} and as source data for [Fig. 4a](#F4){ref-type="fig"}. For detail on identifying CD-NTases within an organism of interest or organisms encoding a CD-NTase of interest, see [Supplementary Discussion](#SD2){ref-type="supplementary-material"}.

Each sequence was identified from the nonredundant database of protein sequences and, at times, represents identical proteins translated from genes found in multiple bacteria. For this reason, additional metadata was extracted for each sequence from the NCBI Identical Protein Groups (IPG) database. The number of "Protein Accessions" in IPG was used as a surrogate quantification of the number of isolated bacterial genomes that harbor each CD-NTase. At the time of access (02/03/2018) 5,686 nonredundant CD-NTases sequences were identified representing a total of 16,717 genomes. At that time, 130,135 bacterial genomes had been deposited in the NCBI Genome database, leading to the crude approximation of 12.8% of genomes harboring CD-NTase genes. As some of these genomes may harbor more than one CD-NTase and the IPG database can overestimate number of genomes encoding a given protein we have estimated that \>10% of bacterial genomes sequenced encode CD-NTases. Taxonomic analysis was performed using metadata associated with each nonredundant CD-NTase record in NCBI and when multiple bacteria were represented by one identical sequence the highest common taxonomical group was used. IPG and Taxonomic data are also found in [Supplementary Table 2](#SD1){ref-type="supplementary-material"}.

Type CD-NTase enzymes were manually selected from clusters based on the relevance of the organism from which they were isolated (i.e. human or plant pathogen/commensal organism), their predicted aptness for *in vitro* expression (thermophilic organisms or isolates from *E. coli*), the similarity of their operon to the DncV/CdnE operons, and the number of identical protein sequences represented by each unique sequence. CD-NTase001 was selected as and additional control and is encoded by *dncV*~*E.\ coli*~ in ECOR31^[@R50]^.

CD-NTase screen {#S27}
---------------

Each type CD-NTase gene was codon optimized for *E. coli*, synthesized (IDT), cloned as an N-terminal 6×His-MBP-fusion, and the protein was purified from a 25 mL culture. *E. coli* growth, protein induction, and bacterial disruption were performed as described above. Lysates were clarified by centrifugation and Ni-NTA affinity purification was performed as described above with gravity columns replaced by spin columns at 100 × g. Buffer exchange of eluted proteins was performed by concentrating the eluate using a 0.5 mL 10 kDa cut-off spin column (Ambion) followed by dilution with storage buffer and re-concentration 3× (final imidazole concentration \~0.3 mM). Proteins were analyzed for nucleotide synthesis fresh and flash-frozen for storage at −80 °C. For biochemical screen, ATP/CTP/GTP/UTP were used at 25 μM each and incubated overnight with the reaction conditions indicated using methods described above. 1 μL of screened protein (\~1 μg) was added to the reaction and the same volume assessed by SDS-PAGE followed by coomassie staining, shown in [Extended Data Fig. 6g](#F11){ref-type="fig"}.

[Fig. 4d](#F4){ref-type="fig"} was manually constructed based on known TLC migration patterns which guided CDN identification in each sample. The quantity of ions detected by MS relative to other CD-NTases was used to determine if products were a major or minor constituent. On PEI-Cellulose, cyclic dipurines migrate similarly, cyclic purine--pyrimidine hybrids migrate similarly, and cyclic dipyrimidines migrate similarly; on Silica c-di-AMP migrates uniquely, cyclic UMP--AMP and cGAMP migrate similarly, c-di-GMP and c-di-UMP migrate similarly, and cGMP--UMP and cCMP--UMP migrate similarly, these cannot be distinguished.

Coexpression of CD-NTases and effectors in E. coli {#S28}
--------------------------------------------------

CD-NTases chosen for in-depth analysis were cloned into an arabinose-inducible, chloramphenicol resistant pBAD33 plasmid. Putative CD-NTase effector genes were selected based on proximity, if they were classified as involved in biological conflict^[@R22]^, and based on analogous operon architecture to known effector phospholipases. Effector genes were codon optimized for *E. coli* and cloned into pETSUMO2^[@R30]^, a carbenicillin resistant vector that is IPTG inducible in BL21-DE3 *E. coli* (ThermoFisher Scientific). Three pairs of vectors were assessed for each CD-NTase-effector pair: (1) cogant CD-NTase + effector, (2) CD-NTase + GFP, (3) mCherry + effector. Fluorescent proteins were used as negative controls. Vectors were co-transformed into electrocompetent BL21-DE3 *E. coli*, selected with both relevant antibiotics, and maintained under non-inducing conditions (0.2% glucose). Overnight bacterial cultures were serially diluted into LB and 5 μL was spot plated on selective medium containing 5 μM IPTG and 0.2% arabinose. Colony formation was quantified and images were taken at \~24 h.

Extended Data {#S30}
=============

![Detailed characterization of CdnE, a cUMP--AMP synthase.\
**a and b,** Titration of reaction buffer pH in steps of 0.2 pH units. Recombinant DncV or CdnE was incubated with α−^32^P radiolabeled ATP, CTP, GTP, and UTP at varying pH and the reactions were treated with alkaline phosphatase and visualized by PEI-cellulose TLC. CdnE activity is optimal at pH \~9.4, and this reaction condition was used in further experiments. Data are representative of 2 independent experiments.\
**c,** PEI-cellulose TLC of products after incubation of indicated enzyme, wild-type CdnE, or active site mutant CdnE with α−^32^P radiolabeled ATP, CTP, GTP, and UTP as in [Fig. 1b](#F1){ref-type="fig"}. Mutations that ablate the CdnE Mg^2+^-coordinating, active-site residues eliminate all detectable activity. Data are representative of 3 independent experiments.\
**d,** Nuclease P1 sensitivity of CDN products. The endonuclease P1 specifically cleaves 3′--5′, canonical phosphodiester bonds. DncV and CdnE products are completely digested in the presence of P1 and alkaline phosphatase, whereas only one bond of 2′3′ cGAMP is susceptible to digestion, producing the linear G\[2′--5′\]pA product. Data are representative of 3 independent experiments.\
**e,** Workflow of nucleotide production for MS and NMR analysis.\
**f,** Anion exchange chromatography of a CdnE reaction with ATP and UTP, eluted with a gradient of Buffer B (2 M ammonium acetate) by FPLC. Individual fractions were concentrated prior to pooling for further analysis.\
**g,** Anion exchange chromatography (IEX) fractions from **f** were separated by silica TLC, visualized by UV shadowing, and compared to a radiolabeled reaction to confirm the appropriate A~254~ peak. Fractions were pooled and concentrated prior to MS and NMR analysis.\
**h, k, and l,** 3′3′ cyclic uridine monophosphate--adenosine monophosphate proton NMR spectra and associated zoomed in datasets. ^1^H NMR (400 MHz): δ~Η~ 8.40 (s, 1H), 8.17 (s, 1H), 7.90 (d, *J* = 8.2 Hz, 1H), 6.15 (s, 1H), 5.75 (s, 1H), 5.55 (d, *J* = 8.2 Hz, 1H), 5.00--4.90 (m, 2H), 4.80 (d, *J* = 4.5 Hz, 1H) 4.70--4.61 (m, 1H), 4.55--4.38 (m, 4H), 4.17--4.02 (m, 2H)\
**i and j,** 3′3′ cyclic uridine monophosphate--adenosine monophosphate phosphate NMR spectra and associated zoomed in dataset. ^31^P{^1^H} NMR (162 MHz): δ~P~ −1.59 (s, 1P), −1.65 (s, 1P).](nihms-1518858-f0006){#F6}

![DncV, cGAS, and CdnE reaction order.\
**a--c,** Incubation of CD-NTase enzymes with nonhydrolyzable nucleotides traps reaction intermediates and identifies reaction order. Left, PEI-cellulose TLC analysis of reactions as in [Fig. 1b](#F1){ref-type="fig"} where individual NTPs have been replaced with nonhydrolyzable nucleotide analogs. Exposed gamma phosphates are labeled in parenthesis to indicate these are removed by phosphatase treatment prior to analysis. Data are representative of 3 independent experiments. Right, previously determined reaction mechanisms (DncV and cGAS)^[@R10],[@R51]^ and proposed reaction mechanism for CdnE.](nihms-1518858-f0007){#F7}

![Detailed analysis of Rm-CdnE.\
**a,** A thermophilic homolog of CdnE from *Rhodothermus marinus* (Rm-CdnE) also synthesizes cUMP--AMP. Recombinant proteins were incubated with α−^32^P radiolabeled NTPs as indicated at either 37 °C (CdnE) or 70 °C (Rm-CdnE) and the reactions were visualized by PEI-cellulose TLC as in [Fig. 1b](#F1){ref-type="fig"}. Data are representative of 2 independent experiments.\
**b,** Active site of Rm-CdnE superimposed with structures of cGAS (6CTA^[@R30]^) and DncV (4TY0^[@R10]^).\
**c,** The analogous position to N166 was mutated in CdnE to a serine and that protein, CdnE^N166S^, was characterized in depth. Reactions analyzed as in [Fig. 1b](#F1){ref-type="fig"}, demonstrate that CdnE^N166S^ loses pyrimidine-specificity. Data are representative of 2 independent experiments.\
**d**, Structure-based sequence alignment of CD-NTases, annotated with secondary structure features of Rm-CdnE and human cGAS (6CTA^[@R30]^). Mg^2+^ coordinating active site residues are highlighted in red, and the analogous residues to Rm-CdnE N166 are highlighted in orange.](nihms-1518858-f0008){#F8}

![Detailed structural analysis of Em-CdnE.\
**a**, Sequence alignment of CdnE homologs in [Fig. 2c](#F2){ref-type="fig"}, annotated with Rm-CdnE secondary structure features. Mg^2+^ coordinating active site residues are highlighted in red, and the analogous residues to Rm-CdnE N166 are highlighted in orange. WP_050915017, *Yersinia enterocolitica*; WP_096075289, *Pseudomonas aeruginosa*; WP_104644370, *Xanthomonas arboricola*; WP_010848498, *Xenorhabdus nematophila*; WP_015040391, *Bordetella parapertussis*; WP_006482377, *Burkholderia cepacia complex*; WP_014072508, *Rhodothermus marinus* (Rm-CndE); WP_042646516, *Legionella pneumophila*; WP_062886322, *Mycobacterium avium*; WP_016200549, *Elizabethkingia meningoseptica* (Em-CdnE); WP_031901603, *Staphylococcus aureus*; WP_050492554, *Enterococcus faecalis*; WP_062695386, *Bacteroides thetaiotaomicron*.\
**b,** Biochemical deconvolution of Em-CdnE, which has a natural serine substitution at the N166 analogous site. Recombinant protein was incubated with NTPs as indicated and reactions were visualized as in [Fig. 1b](#F1){ref-type="fig"}. Data are representative of 3 independent experiments.\
**c,** Reactions of Em-CdnE incubated with α−^32^P radiolabeled NTPs and nonhydrolyzable nucleotide analogs as indicated, and visualized as in [Fig. 1b](#F1){ref-type="fig"}. Data are representative of 3 independent experiments.\
**d,** Anion exchange chromatography of an Em-CdnE reaction with ATP and GTP, eluted with a gradient of Buffer B (2 M ammonium acetate) by FPLC. Individual fractions were concentrated prior to pooling for further analysis.\
**e,** Anion exchange chromatography (IEX) fractions from **d** were separated by silica TLC, visualized by UV shadowing, and compared to a radiolabeled reaction to confirm the appropriate peak. Fractions were pooled and concentrated prior to MS analysis. MS confirmed synthesis of products with masses corresponding to c-di-AMP, cGAMP, and c-di-GMP.\
**f,** Crystal structure of Em-CdnE in complex with GTP and nonhydrolyzable ATP capturing the "1^st^ state" structure prior to NTP hydrolysis. Mg^2+^ ions are omitted for clarity.\
**g**, Zoom-in cut-away of the active site of **f**, confirming position of a serine at the analogous site to Rm-CdnE N166. Mg^2+^ ions are shown in green. Nucleotide and metal 2F~o~−F~c~ electron density is contoured at 1 σ.\
**h,** Zoom-in cut-away of the active site of Em-CdnE--pppApA structure, capturing the "2^nd^ state" after the first reaction has occurred to form a linear intermediate, but prior to CDN formation. Mg^2+^ ions are shown in green. Nucleotide and metal 2F~o~−F~c~ electron density is contoured at 1 σ.\
**i,** Biochemical deconvolution of mutant Em-CdnE reverted to the ancestral asparagine at the N166 analogous site. This mutant loses preference for producing cyclic dipurine molecules and instead produces more pyrimidine-containing CDN products. Reactions were visualized as in [Fig. 1b](#F1){ref-type="fig"}. Data are representative of 2 independent experiments.](nihms-1518858-f0015){#F9}

![cUMP--AMP-recognition helps define innate immune receptor specificity.\
**a and e**, Quantification of nucleotide interactions with the host receptors STING or RECON, measured with radiolabeled nucleotide bound to a concentration gradient of host protein, separated in a native PAGE gel shift (0, 4, 20, 100 µM protein). Data are quantification of gels in **b** and **f** and representative of n=2 independent experiments.\
**b- and f,** Native PAGE gel shift analysis of STING or RECON complex formation with indicated radiolabeled CDNs. Proteins are titrated at 0 (--), 4, 20, and 100 µM. For quantification see **a** and **e**. STING readily binds all cyclic dipurine species but does not form a high-affinity complex with cUMP--AMP. RECON readily binds all 3′3′ CDN species that contain at least one adenine base, including cUMP--AMP. Data are representative of 2 independent experiments.\
**c,** In-cell STING reporter assay. Induction of an IFN-β reporter in HEK293T cells transfected with a concentration gradient of plasmid overexpressing enzymes as indicated. DncV and CdnE were expressed with N-terminal MBP tags and IFN-β reporter induction was compared as fold over empty vector, shown as (−). Data are mean ± SEM for n=3 technical replicates, and are representative of 2 independent experiments.\
**d,** Western blot of MBP-tagged DncV and CdnE expressed from plasmids analyzed in **c** to validate *in vivo* expression. Data are representative of 2 independent experiments. Gel source data are available as [Supplementary Figure 1](#SD2){ref-type="supplementary-material"}.\
**g,** Gel shift analysis as in **f**, with protein titration to measure the relative affinity of the RECON--cUMP--AMP interaction. Protein concentrations listed below. Data are representative of 2 independent experiments.](nihms-1518858-f0009){#F10}

![A biochemical screen of CD-NTases from diverse bacterial genera.\
**a-,** Chart of the number of bacterial genomes (N = a total 16,717) that harbor CD-NTases from clusters in [Fig. 4a](#F4){ref-type="fig"}. See also [Supplementary Table 2](#SD1){ref-type="supplementary-material"}.\
**b-,** Taxa of genome sequenced bacteria isolated with unique CD-NTase genes, bold face type indicate phyla, Proteobacteria and Firmicutes are further divided by order and visualized by shades of color.\
**c-f-,** Type CD-NTases interrogated for product synthesis. Purified proteins were incubated with α−^32^P radiolabeled NTPs under different reaction conditions (indicated pH and divalent cation) and reaction products were visualized by either PEI-cellulose or Silica TLC as in [Fig. 1b](#F1){ref-type="fig"} and [Fig. 4c](#F4){ref-type="fig"}.\
**g,** CD-NTase expression level and purity. Coomassie stained SDS-PAGE analysis of purified CD-NTase enzymes used in each reaction. Data are representative of 2 independent experiments.](nihms-1518858-f0010){#F11}

![Detailed biochemical analysis of Lp-CdnE02.\
**a-,** Biochemical deconvolution of Lp-CdnE02 (CD-NTase057) as in [Fig. 1c](#F1){ref-type="fig"}, demonstrates specific synthesis of cyclic dipyrimidine products. Data are representative of 3 independent experiments.\
**b,** Nuclease sensitivity of the Lp-CdnE02 product, as described in [Extended Data Fig. 1d](#F6){ref-type="fig"}. Data are representative of 3 independent experiments.\
**c,** Incubation of Lp-CdnE02 with nonhydrolyzable nucleotides, as described in [Extended Data Fig. 2](#F7){ref-type="fig"}. Nonhydrolyzable UTP completely blocks the reaction, indicating the first step requires attack of the α-P from UTP. However, the product formed when nonhydrolyzable CTP is present cannot be distinguished from c-di-UMP in this assay, and it is unclear if the reaction proceeds through a pppCpU reaction intermediate. Data are representative of 3 independent experiments.\
**d,** Anion exchange chromatography of a Lp-CdnE02 reaction with UTP and CTP, eluted with a gradient of Buffer B (2 M ammonium acetate) by FPLC. Individual fractions were concentrated prior to pooling for further analysis.\
**e,** Anion exchange chromatography (IEX) fractions from **d** were separated by silica TLC, visualized by UV shadowing, and compared to a radiolabeled reaction to confirm the appropriate peak. Fractions were pooled and concentrated prior to MS analysis.\
**f**, MS confirmed synthesis of c-di-UMP as the major product of Lp-CdnE02.\
**g**, MS confirmed synthesis of cCMP--UMP as a minor product of Lp-CdnE02.](nihms-1518858-f0011){#F12}

![CD-NTases are encoded in conserved, poorly understood operons on mobile genetic elements.\
**a-,** Operon structure for CD-NTases selected for in-depth characterization showing the conserved protein domains in CD-NTase adjacent genes (see [Fig. 4a--c](#F4){ref-type="fig"}). Conserved operons were first identified by Burroughs et al. and operons are vertically organized by similarity to one another^[@R22]^. Where found, linked genes demonstrating CD-NTases are encoded on mobile genetic elements are indicated.\
**b,** CD-NTases and their adjacently encoded "effector" proteins were coexpressed in *E. coli* and bacterial colony formation was quantified by spot dilution analysis. CD-NTases were inducibly expressed from a chloramphenicol resistant (Cm^R^) vector and effectors were inducibly expressed from a carbenicillin resistant (Carb^R^) vector. Bacteria harboring cognate CD-NTase / effector plasmids or control plasmids were plated on medium containing both inducers and incubated for 24 h at 37 °C. Data were not determined (N.D.) for CD-NTase036 because the effector was toxic to *E. coli* under non-inducing conditions. Data are the mean ± SEM of 3 independent experiments.\
**c,** Spot dilution analysis of bacteria harboring the cognate CD-NTase-effector pair indicated, as quantified in **b**. The CD-NTase036-effector pair was not analyzed in this assay. Colony morphology indicates a potential interaction for some combinations, however, it is unclear how specific or significant this may be. Data are representative of 3 independent experiments.](nihms-1518858-f0012){#F13}

![Detailed biochemical analysis of Ec-CdnD02.\
**a-,** Titration of reaction buffer pH in steps of 0.2 pH units. Recombinant Ec-CdnD02 was incubated with α−^32^P radiolabeled NTPs at varying pH and the reactions were analyzed and visualized by PEI-cellulose or silica TLC as in [Fig. 1b](#F1){ref-type="fig"} and [Fig. 4c](#F4){ref-type="fig"}. Silica TLC identified two products, denoted the major (blue triangle) and minor (red triangle) product. Quantification of TLC spots is shown below. Data are representative of 2 independent experiments.\
**b-,** Biochemical deconvolution of Ec-CdnD02, recombinant protein was incubated with NTPs as indicated and analyzed by TLC as in **a**. Data are representative of 3 independent experiments.\
**c-,** Nuclease digestion of the Ec-CdnD02 product. Conventional nuclease digestion includes addition of a phosphatase, in this experiment reactions were first treated with Antarctic phosphatase to remove remaining NTPs then heat inactivated. Next, reactions were either untreated, treated with nuclease P1 (specific for 3′--5′ phosphodiester bonds) only, or treated with nuclease P1 and phosphatase to remove exposed phosphate groups. 3′3′ cGAMP (DncV) and Ec-CdnD02 product are digested into AMP and GMP constituents, which are phosphatase sensitive. cAMP (CyaA) is insensitive to P1 digestion and cyclic monophosphates are phosphatase resistant. These data demonstrate that the Ec-CdnD02 product does not contain a cyclic monophosphate. Data are representative of 3 independent experiments.\
**d,** Incubation of Ec-CdnD02 with nonhydrolyzable nucleotides, as described in [Extended Data Fig. 2](#F7){ref-type="fig"}. Nonhydrolyzable ATP completely blocks the reaction, indicating the first step requires attack of the α-P from ATP. However, when nonhydrolyzable GTP is present the possible intermediates \[pp(c)pGpA, pp(c)pGpApA, or pppApA\] cannot be distinguished in this assay and it is unclear how the reaction proceeds. Silica TLC is not suited for analyzing nonhydrolyzable nucleotides because they do not migrate beyond the origin. Data are representative of 3 independent experiments.\
**e,** Anion exchange chromatography of a Ec-CdnD02 reaction with ATP and GTP, eluted with a gradient of Buffer B (2 M ammonium acetate) by FPLC. Individual fractions were concentrated prior to pooling for further analysis.\
**f and g,** 3′3′3′ tricyclic adenosine monophosphate--adenosine monophosphate--guanosine monophosphate (cAAG) NMR spectra and associated zoomed in dataset. ^31^P{^1^H} NMR (162 MHz): δ~P~ −0.65 (s, 1P), −0.70 (s, 1P), −0.75 (s, 1P).\
**h-j,** 3′3′3′ tricyclic adenosine monophosphate--adenosine monophosphate--guanosine monophosphate (cAAG) proton NMR spectra and associated zoomed in datasets. ^1^H NMR (400 MHz): δ~Η~ 8.43 (s, 1H), 8.39 (s, 1H), 8.19 (s, 1H), 8.12 (s, 1H), 8.01 (s, 1H), 6.15 (d, *J* = 7.0 Hz, 1H), 6.12 (d, *J* = 7.0 Hz, 1H), 5.92 (d, *J* = 7.5 Hz, 1H), 5.00--4.78 (m, 6H), 4.69--4.58 (m, 3H), 4.3--4.2 (m, 6H).](nihms-1518858-f0013){#F14}

![Structural analysis of cAAG inhibition of RECON.\
**a,** cAAG interactions with STING or RECON, radiolabeled nucleotide incubated with a concentration gradient of each protein, separated in a native PAGE gel shift (0, 4, 20, 100 µM protein). Data are representative of 2 independent experiments.\
**b,** Co-crystal structure of the RECON--cAAG complex shown as cartoon (left) and surface (right).\
**c,** Overlay and orientation of RECON ligands cAAG, c-di-AMP (5UXF), co-substrate NAD (3LN3) demonstrate three individual binding pockets.\
**d,** Schematic representation of residues from RECON that interact with cAAG. Green dotted lines indicate hydrogen bonding, grey dotted lines indicate hydrophobic interactions.\
**e**, Zoom-in cutaways of individual RECON binding pockets as in **d**.\
**f,** Mammalian innate-immune sensors recognize CD-NTase products with overlapping specificities. 2′3′ cGAMP and c-di-GMP are detected by STING; 3′3′ cGAMP and c-di-AMP are detected by both STING and RECON; and cUMP--AMP and cAAG are detected by RECON.](nihms-1518858-f0014){#F15}
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![Bacteria synthesize cyclic UMP--AMP.\
**a,** An *E. coli* genomic island homologous to the *Vibrio* seventh pandemic island-I (VSP-I) encodes a 3′3′ cGAMP synthase (*dncV*) and phospholipase receptor (*capV*). The ECOR31 island encodes a second *capV*-like gene (BHF03_01995 encoding WP_001593459, renamed *capE*) adjacent to a gene of unknown function (BHF03_01990 encoding WP_001593458, renamed *cdnE*).\
**b,** PEI-cellulose TLC of enzyme reactions. Purified CdnE was incubated with α−^32^P radiolabeled ATP, CTP, GTP, and UTP. Reactions were terminated by treating with alkaline phosphatase to remove exposed triphosphates. Standards are 2′3′ cGAMP (cGAS), 3′3′ cGAMP (DncV), c-di-AMP (DisA), and c-di-GMP (WspR). Data are representative of 3 independent experiments.\
**c,** Biochemical deconvolution of the CdnE reactions as in (b) after incubating with α−^32^P labeled and unlabeled NTPs. Data are representative of 3 independent experiments.\
**d,** The CdnE product, confirmed by mass spectrometry (MS) and NMR (see [Extended Data Fig. 1e--l](#F6){ref-type="fig"}).\
**e,** Activation of CapV and CapE by CDNs, tested with no nucleotide added (−) or at 0.1, 1, and 10-fold molar ratios of nucleotide to phospholipase. Enzyme activity is reported in Phospholipase A~1~ units mL^−1^. Data are mean ± standard error of the mean (SEM) for n=3 technical replicates and are representative of 3 independent experiments.](nihms-1518858-f0001){#F1}

![Conserved active site residues dictate CD-NTase specificity.\
**a,** Crystal structure of Rm-CdnE in complex with nonhydrolyzable ATP and UTP analogs and zoom-in inset of key N166--uridine contacts controlling pyrimidine specificity. Green dotted lines indicate hydrogen bonding and 2F~o~−F~c~ electron density map is contoured at 1 σ.\
**b,** Phylogram of CdnE sequence homologs and their N166 analogous residue determined by sequence alignment ([Extended Data Fig. 4a](#F9){ref-type="fig"}). Red "S's" highlight cGAS / DncV-like serine residues.\
**c,** CdnE homolog and mutant reactions analyzed by TLC as in [Fig. 1b](#F1){ref-type="fig"}. "N" vs red "S" indicate asparagine or cGAS / DncV-like serine at the N166 analogous position in the tested allele. Side-chains are numbered according to Rm-CdnE sequence. Data are representative of 3 independent experiments. For detailed deconvolution and purine vs pyrimidine migration pattern analysis see Extended Data Fig. [3](#F8){ref-type="fig"} and [4](#F9){ref-type="fig"}.\
**d,** Structure-based comparisons define that Rm-CdnE and Em-CdnE are cGAS / DncV-like nucleotidyltransferase (CD-NTases) with a similar architecture to DncV (4TY0), cGAS (6CTA), and OAS1 (4RWO). CD-NTases are more distantly related to Pol-β-like NTases: Pol-μ (4YD1), Pol-β (4KLQ), CCA-adding enzyme (4X4T), and Poly(A) Polymerase gamma (PAP, 4LT6). The NTase core domain for each enzyme is clustered according to Z-score and colored in magenta/blue.](nihms-1518858-f0002){#F2}

![Immune detection of a pyrimidine containing CDN.\
**a,** In-cell STING reporter assay. Induction of an Interferon-β (IFN-β) reporter in HEK293T cells transfected with a concentration gradient of plasmid overexpressing enzymes as indicated. cGAS synthesizes 2′3′ cGAMP, DncV synthesizes 3′3′ cGAMP, DisA synthesizes c-di-AMP, WspR synthesizes c-di-GMP, and CdnE synthesizes cUMP--AMP. Data are fold induction over vector only, shown as (−), are mean ± SEM for n=3 technical replicates, and are representative of 3 independent experiments.\
**b,** Nucleotide inhibition of RECON enzymatic activity, as measured by oxidation of NADPH co-substrate. X-axis is a log scale and data are representative of 3 independent experiments.](nihms-1518858-f0003){#F3}

![CD-NTases synthesize diverse nucleotide products and form a family of enzymes abundant in many bacterial phyla.\
**a**, Bioinformatic identification and alignment of \~5,600 predicted CD-NTases found in nearly every bacterial phylum, shown as an unrooted tree. Sequence-related enzymes that are \~10% identical are grouped by lettered clade and similarly colored, enzymes \~25% identical are grouped by cluster in a similar color shade. Circles represent CD-NTase001--066 that were selected as type CD-NTases for a biochemical screen (See [Extended Data Fig 6](#F11){ref-type="fig"} for additional details). Blue circles denote CD-NTases selected for in-depth characterization and are labeled with CD-NTase numbers from the biochemical screen (see Fig. 4b, CdnE is "56" and DncV is "D"). For additional information, see [Supplementary Discussion](#SD2){ref-type="supplementary-material"}, [Supplementary Table 2](#SD1){ref-type="supplementary-material"}, and source data for this figure provided as [Supplementary Data](#SD2){ref-type="supplementary-material"}.\
**b and c**, PEI-cellulose and silica TLC analysis of 16 CD-NTases selected for in-depth characterization. Activity was analyzed with α−^32^P radiolabeled NTPs as in [Fig. 1b](#F1){ref-type="fig"}. Wild-type (WT) and catalytically inactive mutant (mt) DncV reactions are included as controls. Screened CD-NTases were numbered CD-NTase001--066. CD-NTase056 is CdnE, CD-NTase057 was renamed Lp-CdnE02, and CD-NTase038 was renamed Ec-CdnD02. These appear as "56", "57", and "38" in Fig. 4a, respectively. Data are representative of 3 independent experiments.\
**d,** Identification of CD-NTase products by combining TLC and MS data. CD-NTases that synthesize a major product that could not be matched with a predicted CDNs are denoted as "unknown."](nihms-1518858-f0004){#F4}

![Bacterial synthesis and host recognition of a cyclic trinucleotide.\
**a,** Silica TLC analysis of the Ec-CdnD02 (CD-NTase038) product and control reactions as in [Fig. 1b](#F1){ref-type="fig"}. The major product of Ec-CdnD02 is indicated with a triangle and incorporates \~2× greater α−^32^P from ATP than α−^32^P from GTP. Data are representative of 3 independent experiments.\
**b,** The major product of Ec-CdnD02, cyclic AMP--AMP--GMP (cAAG), confirmed by MS and NMR, see [Extended Data Fig. 9](#F14){ref-type="fig"} for additional characterization.\
**c,** cAAG inhibition of RECON enzymatic activity, as measured by oxidation of NADPH co-substrate. X-axis is a log scale and data are representative of 3 independent experiments.\
**d,** Co-crystal structure of the host receptor RECON in complex with cAAG, and inset highlighting the cAAG 2F~o~−F~c~ electron density contoured at 1.3 σ. Green dotted lines indicate hydrogen bonding, some RECON--cAAG contacts omitted for clarity, see [Extended Data Fig. 10](#F15){ref-type="fig"}.](nihms-1518858-f0005){#F5}
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